01—History
Accounts Payable History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $317.0M
2 older moves run past ±150% (largest +1577.8%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is Moderna, Inc.'s current accounts payable?
Moderna, Inc. (MRNA) annual accounts payable for 2025 was $317.0M, a 21.73% decline from 2024. Moderna, Inc. accounts payable for the quarter ending March 31, 2026 was $161.0M.
What was Moderna, Inc.'s accounts payable in 2024?
Moderna, Inc. annual accounts payable for 2024 was $405.0M, a 22.12% decline from 2023.
What was Moderna, Inc.'s accounts payable in 2023?
Moderna, Inc. annual accounts payable for 2023 was $520.0M, a 6.78% increase from 2022.
What is Moderna, Inc.'s 5-year accounts payable CAGR?
Moderna, Inc. accounts payable grew at a compound annual growth rate (CAGR) of 77.48% from FY2020 to FY2025, going from $18.0M to $317.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)